Research Webinars

The main PxP conference will take place again in Fall of 2024. Ahead of this, we are delighted to launch a webinar series in collaboration with the Patient Engagement Research Ambassadors (PERA) at CIHR-IMHA. We are very grateful to PERA for developing four webinars that will be held virtually across 2024 on the PxP Zoom platform. As with the main conference, the sessions will be completely free to attend and a recording will be shared afterwards. Closed captioning is available and live translated captions in over 30 languages.

Learning Objectives:Understand the fundamental concepts behind the use of EthOss in implantology, exploring the reasoning and traditional scientific approaches involved in the research process.Explore how AI has been utilised to study the impact of EthOss, including the generation of accurate illustrations and detailed descriptions related to immune cells and foreign body reactions.Explore the role of AI, specifically Natural Language Processing (NLP), in processing studies related to osteoimmunology and implantology, and why NLP should be considered well-suited for this purpose.Gain insights into the methodology of using AI, specifically Large Language Models (LLM), to conduct literature searches, formulate research questions, and generate hypotheses in the field of implantology.Learners will be able to:Investigate the practical implications of EthOss in implantology, focusing on its potential as more than just a graft but as a catalyst for healing, and understand the specific scenarios where EthOss can be beneficial.Examine the methodology of incorporating EthOss into the research process, including the formulation of research questions, and hypotheses and how AI, without complex programming, aids in extracting valuable insights from studies.Explore the long-term implications of EthOss in implantology, considering its potential impact on improving patient outcomes, reducing recovery times, and advancing the field of osteoimmunology.Discover the practical application of AI in the analysis of Beta-tricalcium Phosphate and Calcium Sulphate in the context of foreign body reaction modulation.

Lum Kastrati is an MD by training and a visiting researcher at Stanford University as part of his PhD journey in Epidemiology and Biostatistics at the University of Bern. In this session you will be informed on the opportunities and challenges of choosing the research path after medical school.

ESG-related regulatory movements and the evolving priorities of key stakeholders are pressurizing firms to report on sustainability metrics and improve sustainability performance. As organizations realise that internal expertise and bandwidth are not enough to navigate a quickly evolving sustainability landscape, they are increasingly seeking support from ESG and sustainability consulting firms for their sustainability journeys. Based on our Green Quadrant report, this webinar will provide exclusive insights into the top ESG and sustainability consulting providers in the industry. During this session, Verdantix experts will evaluate 17 of the most prominent ESG and sustainability consulting providers across 5 capability and 6 momentum categories, offering analysis based on a robust and respected methodology. Attendees will: Gain in-depth knowledge about the leading ESG and sustainability consulting providers and their capabilities Understand how these providers can help your organizations navigate regulatory complexities and stakeholder demands Explore the current state of the market including buyer priorities and preferences

Discover this groundbreaking webinar delving into the latest insights from the Cross-Company Abuse Liability Council (CCALC) and The Food and Drug Administration (FDA) in drug development and clinical evaluation of human drug abuse and dependence potential. This webinar aims to discuss current knowledge and recent updates on the clinical evaluation of the abuse and dependence potential of drugs.

This webinar outlines the many ways that you can benefit from IDT’s xGen NGS solutions for cancer research. Join to discover:High library complexity from low-quality samplesPredesigned and custom approaches for hybridization captureComplete sample preparation workflow for minimal residual disease (MRD) researchAwareness to our Research Oncology ProductsPresenters:Derek Pappas: Field application specialist, Integrated DNA TechnologiesJason Santos (Moderator): Senior strategic marketing manager, Integrated DNA Technologies

A metagenome is a sequencing sample of a bulk microbial community, providing a genetic snapshot of the entire microbiome sampled. Metagenomics offers a comprehensive genetic overview of microbial communities, without the limitations of culture-based methods. The introduction of the shotgun method of metagenomics has added the ability to quantify the phylogenetic and functional roles of microbes without primer bias. As sequencing becomes more affordable, shotgun metagenomics is becoming an increasingly popular method for assessing microbiomes.This webinar will offer a brief introduction to metagenomics and discuss various concepts and methods used in modern metagenomics. Specifically, we will explore topics such as using microbial composition as an indicator of ecosystem state, using functional genes as biosensors, and the insights that can be gleaned from genomic structure.

Dr. Aysenur Korkmaz joins us to present her research on Armenian Heritage in Eastern Turkey also known as Western Armenia

This webinar will give an overview of NIJ’s Graduate Research Fellowship opportunity, which invites applications for doctoral dissertation research that is relevant to preventing and controlling crime, advancing knowledge of victimization and effective victim services, or ensuring the fair and impartial administration of criminal or juvenile justice in the United States. This solicitation is open to doctoral students in all science and engineering fields.The presenters will discuss program scope, eligibility, application elements, and frequently asked questions. To use the time most efficiently, NIJ encourages participants to review the solicitation and submit any questions they may have in advance and no later than February 12, 2024. Submit your questions to grf@usdoj.gov with the subject as “Questions for GRF Webinar.” Live captioning will be available.

Adapting Endpoints, Ensuring Data Quality, and Determining Clinical Meaningfulness of Trial Results. Testing new therapeutic candidates in patients with rare diseases presents considerable challenges for clinical trial teams. In this webinar, Dr. Pam Ventola will share methodological approaches for adapting endpoints for rare disease trials and discuss rater training approaches and targeted data quality monitoring methodologies specific to rare disease trials. Dr. Ventola will also outline approaches for supporting the clinical meaningfulness of results in rare disease trials.